Get the Stockscreener App
18.53
3.39%
-0.65
Erasca Inc stock is traded at $18.53, with a volume of 3.02M.
It is down -3.39% in the last 24 hours and up +38.59% over the past month.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.
See More
Previous Close:
$19.18
Open:
$18.91
24h Volume:
3.02M
Relative Volume:
0.45
Market Cap:
$5.76B
Revenue:
-
Net Income/Loss:
$-277.02M
P/E Ratio:
-19.86
EPS:
-0.9328
Net Cash Flow:
$-91.36M
1W Performance:
+0.32%
1M Performance:
+38.59%
6M Performance:
+174.11%
1Y Performance:
+1,119%
1-Day Range:
$18.10
$19.14
1-Week Range:
$17.91
$20.07
52-Week Range:
$1.3301
$24.28
Erasca Inc Stock (ERAS) Company Profile
Name
Erasca Inc
Sector
Industry
Phone
(858) 465-6511
Address
3115 MERRYFIELD ROW, SAN DIEGO
Compare ERAS vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
18.53 | 5.76B | 0 | -277.02M | -91.36M | -0.9328 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Resumed | Mizuho | Outperform |
| Jan-07-26 | Initiated | Piper Sandler | Overweight |
| Oct-16-25 | Initiated | Stifel | Buy |
| Sep-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-26-25 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | Jefferies | Buy |
| Mar-11-24 | Initiated | CapitalOne | Overweight |
| Jan-05-24 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-11-23 | Initiated | H.C. Wainwright | Buy |
| Mar-30-23 | Initiated | Mizuho | Buy |
| Feb-24-23 | Initiated | Goldman | Buy |
| Feb-03-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Erasca Inc Stock (ERAS) Latest News
ERAS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - GlobeNewswire Inc.
ERAS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Erasca (ERA) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - AOL.com
ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ErascaERAS - PR Newswire
Robbins LLP Urges ERAS Stockholders to Contact the Firm for Information About the Class Action Against Erasca, Inc. - GlobeNewswire
Logos Global Management LP's Erasca Inc(ERAS) Holding History - GuruFocus
Does Erasca’s Shift Into Russell Growth Indexes (ERAS) Quietly Redefine Its Biotech Investment Story? - simplywall.st
Embecta, Erasca, Hub Group, and ZoomInfo Under Investigation for Fiduciary Breaches - Intellectia AI
Attention Long-Term Shareholders of Embecta Corp. (NSADAQ: - GlobeNewswire
ERAS Shareholder Alert: Erasca, Inc. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - GlobeNewswire
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall ... - Caledonian Record
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit - AOL.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Erasca, Inc. - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Erasca, Inc. of Class Action Lawsuit and Upcoming DeadlinesERAS - PR Newswire
Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of ... - Caledonian Record
ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ERAS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Erasca, Inc. Securities LawsuitContact Levi & Korsinsky - Business Wire
ERASCA, INC. (ERAS) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
ERAS DEADLINE NOTICE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - StreetInsider
REMINDER: Erasca, Inc. Investors With Significant Losses Must Act By August 10, 2026 – Kirby McInerney LLP - GlobeNewswire
KVP Capital Advisors, LP's Erasca Inc(ERAS) Holding History - GuruFocus
Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS) - GlobeNewswire
Lost Money on Erasca, Inc. (ERAS)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - PR Newswire
ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-07-08 | ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:ERAS | Press Release - Stockhouse
ERAS INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) I - The National Law Review
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Erasca focuses on targeted cancer therapies as investors assess its long-term prospects - AD HOC NEWS
ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ERAS DEADLINE: Levi & Korsinsky Reminds Erasca, Inc. Investors of Upcoming Securities Class Action Deadline - AOL.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
ERAS DEADLINE ALERT: Erasca, Inc. (ERAS) Investors with - GlobeNewswire
2026-07-07 | ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:ERAS | Press Release - Stockhouse
ERAS Stock Slumps Nearly 40% After-Hours: Fine Print In 'Positive' Cancer Trial Reveals Treatment-Related Death - Stocktwits
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
B of A Securities Downgrades Erasca (ERAS) - MSN
Erasca (ERAS) Faces Securities Class Action After Stock Declines 48% on Drug Safety and IP Concerns-- HBSS - GlobeNewswire
Deadline Alert: Erasca, Inc. (ERAS) Shareholders Who Lost - GlobeNewswire
ERAS UPCOMING DEADLINE: Levi & Korsinsky Alerts Erasca, - GlobeNewswire
ERAS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds - GlobeNewswire
ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, A LEADING LAW FIRM, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionERAS - ACCESS Newswire
ERAS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Erasca (ERA - The National Law Review
Erasca, Inc. Notice of August 10, 2026 Application Deadline for - GuruFocus
ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ERAS INVESTOR REMINDER: Erasca, Inc. Investors Have Until August 10, 2026 to Seek Lead Plaintiff Role - mykxlg.com
Erasca, Inc. (ERAS) Faces Securities Class Action Amid - GlobeNewswire
ERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitHBSS - Sahm
Spruce Street Capital LP's Erasca Inc(ERAS) Holding History - GuruFocus
Erasca Inc Stock (ERAS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):